Detalhe da pesquisa
1.
Phase II study of DFP-10917, a deoxycytidine analog, given by 14-day continuous intravenous infusion for chemotherapy-refractory advanced colorectal cancer.
Invest New Drugs
; 36(5): 895-902, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29948357
2.
A Randomized, Double-Blinded, Phase II Trial of Gemcitabine and Nab-Paclitaxel Plus Apatorsen or Placebo in Patients with Metastatic Pancreatic Cancer: The RAINIER Trial.
Oncologist
; 22(12): 1427-e129, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28935773
3.
Transforming growth factor alpha expression drives constitutive epidermal growth factor receptor pathway activation and sensitivity to gefitinib (Iressa) in human pancreatic cancer cell lines.
Cancer Res
; 66(7): 3802-12, 2006 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16585207
4.
Patterns of self-reported symptoms in pancreatic cancer patients receiving chemoradiation.
J Pain Symptom Manage
; 34(3): 244-52, 2007 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-17513082
5.
Cytotoxic chemotherapy for pancreatic cancer: Advances to date and future directions.
Drugs
; 66(8): 1059-72, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-16789792
6.
Pharmacodynamic analysis of target inhibition and endothelial cell death in tumors treated with the vascular endothelial growth factor receptor antagonists SU5416 or SU6668.
Clin Cancer Res
; 11(2 Pt 1): 678-89, 2005 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15701856
7.
Celecoxib inhibits vascular endothelial growth factor expression in and reduces angiogenesis and metastasis of human pancreatic cancer via suppression of Sp1 transcription factor activity.
Cancer Res
; 64(6): 2030-8, 2004 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15026340
8.
Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis.
Oncogene
; 22(3): 319-29, 2003 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-12545153
9.
Cetuximab, a monoclonal antibody targeting the epidermal growth factor receptor, in combination with gemcitabine for advanced pancreatic cancer: a multicenter phase II Trial.
J Clin Oncol
; 22(13): 2610-6, 2004 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15226328
10.
Prostaglandin E2 drives cyclooxygenase-2 expression via cyclic AMP response element activation in human pancreatic cancer cells.
Cancer Biol Ther
; 4(11): 1263-9, 2005 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-16319525
11.
A pharmacological study of celecoxib and gemcitabine in patients with advanced pancreatic cancer.
Cancer Chemother Pharmacol
; 55(6): 559-64, 2005 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15726370
12.
Phase I and pharmacological study of oral 9-aminocamptothecin colloidal dispersion (NSC 603071) in patients with advanced solid tumors.
Clin Cancer Res
; 9(6): 2066-71, 2003 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12796369
13.
Epidermal growth factor receptor-targeted therapy for pancreatic cancer.
Semin Oncol
; 29(5 Suppl 14): 31-7, 2002 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-12422311
14.
Molecular targeting therapy for pancreatic cancer.
Cancer Chemother Pharmacol
; 54 Suppl 1: S69-77, 2004 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-15316751
15.
Novel therapies for pancreatic adenocarcinoma.
Curr Oncol Rep
; 6(3): 199-206, 2004 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-15066231
16.
Adjuvant therapy for pancreatic cancer: current status and future directions.
Surg Oncol Clin N Am
; 13(4): 737-49, xi, 2004 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-15350945
17.
Experimental animal models of pancreatic carcinogenesis and metastasis.
Int J Gastrointest Cancer
; 33(1): 43-60, 2003.
Artigo
em Inglês
| MEDLINE | ID: mdl-12909737
18.
Phase 2 trial of oxaliplatin plus capecitabine (XELOX) as second-line therapy for patients with advanced pancreatic cancer.
Cancer
; 113(8): 2046-52, 2008 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18756532
19.
Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases.
J Clin Oncol
; 24(13): 2065-72, 2006 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16648507
20.
Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy.
Ann Surg Oncol
; 13(8): 1035-46, 2006 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16865597